Latest Conference

Genevieve Neal-Perry, MD, PhD, highlights that phase 4 real-world data confirm that fezolinetant significantly reduces VMS bother, particularly in high-burden groups such as Black women and patients with obesity.

Progressive menstrual pain should prompt earlier evaluation for endometriosis to prevent missed opportunities and delayed care, Hugh Taylor, MD, explained.

David Shalowitz explains why experts now recommend a dual approach for most patients with postmenopausal bleeding due to limitations in ultrasound accuracy.

Earlier initiation of conservative therapies may improve outcomes and reduce the need for advanced treatment in stress urinary incontinence.

At ACOG, David Shalowitz, MD, highlighted the biggest takeaways from April's updated guidance on postmenopausal bleeding.

Early postpartum visits were associated with a 44% reduction in acute care use among patients with SUD, regardless of care model.

Eduardo Lara-Torre, MD, FACOG, emphasizes that pediatric and adolescent gynecology provides a critical bridge to ensure young patients do not lose access to care as they transition to adult providers.

Eduardo Lara-Torre, MD, FACOG, explains that the unbundling of obstetric codes on January 1, 2027, will allow physicians to bill for each visit individually rather than receiving a single bundled payment.

Members of the BillionToOne team joined us at ACOG to discuss the launch of the new Unity Confirm fetal cell-based test for confirmation of high-risk prenatal screening results.

According to Erick Holder, MD, AI tools can help combat medical misinformation by directing patients toward scientific research and board-certified specialists.

Take a look back at our coverage (so far) of the 2026 ACOG meeting in Washington, DC

At ACOG, Julie Anderson presented data demonstrating that virtual birth planning is associated with a nearly 4-fold increase in shared decision-making for high-risk patients.

Meaningful improvements in gynecologic care for LGBTQ patients require both environmental changes—inclusive waiting rooms, trained front desk staff, flexible scheduling—and clinical recalibration, including routine screening for contraceptive needs and menopausal symptoms regardless of gender identity or presentation.

Pelin Batur, MD, emphasizes that half of patients are unsatisfied with their sexual health and clinicians should normalize these concerns through simple, open-ended questions.

Jill Liss, MD, MSCP, FACOG, outlines aspects of hormonal and non-hormonal treatments for vasomotor symptoms.

During clinical validation done by the company, Unity Confirm demonstrated 100% concordance with known fetal outcomes and invasive diagnostic results in 16 samples.

In this discussion from ACOG's 75th Annual Meeting, Genevieve Neal-Perry, MD, PhD, explains how elinzanetant has impacted patients since it's approval in October 2025.

Molly Dickinson, DO, describes a rare case where a 22-week uterine rupture was repaired allowing the pregnancy to continue to a successful 32-week delivery.

A study of 1206 women found that while many remain sexually active as they age, a higher number of menopausal symptoms was linked to decreased sexual satisfaction.

Contemporary OB/GYN will be on site in Washington, D.C. to cover the latest data out of the 75th Annual ACOG Clinical & Scientific Meeting.

In this video from the 2026 American College of Cardiology Annual Scientific Session & Expo, Amy Sarma, MD, details associations of cardiovascular disease and menopause.

From FDA regulatory updates for products related to women's health, to a preview of upcoming annual meetings and conferences, we keep you updated on what's to come in Q2 of 2026.

Lam-Rachlin reported that the software did not add time to the examinations and, in some instances, appeared to speed up the process by providing a rapid preliminary analysis.

Sara Perelmuter advocates for routine postpartum screening and provider education on lactation-safe therapies when dealing with GSL symptoms.

Sara Perelmuter details how naming Genitourinary Syndrome of Lactation (GSL) is a vital step in addressing the treatment gap in postpartum care.

Julia Ordway highlights a case where unregulated testosterone pellets led to a 2-year recovery period.

Sasha Vereecken explains the potential quality of life and sexual worry benefits of investigational ACT for stress urinary incontinence, as well as who may be best suited for the implant.

A large-scale TriNetX database analysis found no statistically significant difference in the incidence of vulvar atrophy or hypertrophy between non-diabetic women using GLP-1RAs and those who were not.